<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>05944756582869</udiDi>
    <basicUdiDi>B-05944756582869</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX1217</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:28:17.652Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756582814</udiDi>
    <basicUdiDi>B-05944756582814</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX1212</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:28:04.392Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756582807</udiDi>
    <basicUdiDi>B-05944756582807</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX1211</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:28:03.590Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756582555</udiDi>
    <basicUdiDi>B-05944756582555</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX1183</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:27:21.193Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756582548</udiDi>
    <basicUdiDi>B-05944756582548</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX1182</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:27:20.391Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756582531</udiDi>
    <basicUdiDi>B-05944756582531</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX1181</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:27:19.589Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756582524</udiDi>
    <basicUdiDi>B-05944756582524</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX1180</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:27:18.792Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756582517</udiDi>
    <basicUdiDi>B-05944756582517</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX1179</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:27:13.976Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756582456</udiDi>
    <basicUdiDi>B-05944756582456</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX1173</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:27:05.971Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756580209</udiDi>
    <basicUdiDi>B-05944756580209</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX149</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:26:20.334Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756580193</udiDi>
    <basicUdiDi>B-05944756580193</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX148</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:26:19.564Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756580186</udiDi>
    <basicUdiDi>B-05944756580186</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX147</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:26:18.734Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756580179</udiDi>
    <basicUdiDi>B-05944756580179</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX146</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:26:17.930Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756580162</udiDi>
    <basicUdiDi>B-05944756580162</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX145</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:26:13.933Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756580155</udiDi>
    <basicUdiDi>B-05944756580155</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX144</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:26:13.131Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756580148</udiDi>
    <basicUdiDi>B-05944756580148</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX143</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:26:12.332Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756580131</udiDi>
    <basicUdiDi>B-05944756580131</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX142</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:26:11.533Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756580001</udiDi>
    <basicUdiDi>B-05944756580001</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX126</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:23:59.914Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904248292086</udiDi>
    <basicUdiDi>89042482SOL001PE</basicUdiDi>
    <tradeName>Solus</tradeName>
    <deviceName>Braided Coated Polyglycolic acid suture</deviceName>
    <manufacturerName>TI Medical Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000026561</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>TI/C-BRO/01</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:22:38.996Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904248289383</udiDi>
    <basicUdiDi>89042482SOL001PE</basicUdiDi>
    <tradeName>Solus</tradeName>
    <deviceName>Braided Coated Polyglycolic acid suture</deviceName>
    <manufacturerName>TI Medical Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000026561</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>TI/C-BRO/01</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:22:37.792Z</lastUpdated>
  </row>
</eudamedExport>